The Links Between Bacterial Fermentation, SIBO, and Breath Testing
Key Takeaways
Gut microbes produce hydrogen, methane, and hydrogen sulfide as they metabolize carbohydrates and other substances.
When excessive fermentation occurs in the small intestine, microbial gases may contribute to bloating, distension, discomfort, and altered bowel habits.
Some microbial gases enter the bloodstream, travel to the lungs, and can be measured in exhaled breath.
Breath testing can provide useful evidence of SIBO or intestinal methanogen overgrowth, but results are indirect and should be interpreted alongside symptoms, medical history, and other clinical information.
Why Fermentation Matters
Fermentation plays a central role in both the symptoms and diagnosis of small intestinal bacterial overgrowth (SIBO). When gut microbes ferment carbohydrates, they produce gases such as hydrogen and methane that can contribute to bloating, distension, discomfort. Those same gases can also be a helpful indicator of microbial activity in the digestive tract. After they are produced, some gas enters the bloodstream, travels to the lungs, and is exhaled.
Understanding this biological sequence, from fermentation to exhalation, helps explain how excessive fermentation may contribute to SIBO symptoms and how clinicians use breath testing to evaluate for microbial overgrowth.
What Is Bacterial Fermentation?
Fermentation is the process microorganisms use to break down carbohydrates for energy. As they do, they produce a variety of substances, including beneficial compounds and gases. Some of these compounds, such as short-chain fatty acids, support normal gut health.
The gases produced during fermentation, including hydrogen, methane, and hydrogen sulfide, are central to understanding SIBO and breath testing.
Hydrogen (H₂): Produced directly by many carbohydrate-fermenting bacteria.
Methane (CH₄): Produced by methanogenic archaea, which use hydrogen produced by other microbes.
Hydrogen sulfide (H₂S): Produced by certain sulfur-metabolizing bacteria and increasingly recognized in gastrointestinal disorders.
Methane differs from the other gases because it is not produced by bacteria but by methanogenic archaea, a separate domain of microorganisms. This distinction is reflected in the terminology: excess methane production is now described as intestinal methanogen overgrowth (IMO) rather than methane-predominant SIBO.
Where Does Gut Fermentation Normally Happen?
Microbial fermentation occurs throughout the gastrointestinal tract, but extensive carbohydrate fermentation is concentrated primarily in the colon, where microbial density is highest.
The small intestine normally contains a much smaller microbial population. Several systems help regulate microbial numbers there:
Stomach acid and digestive secretions, which help limit microbial survival and growth
Peristalsis and the migrating motor complex, which move food and microorganisms through the small intestine
The ileocecal valve, which helps limit microbes and other contents from the colon moving back into the small intestine
Mucosal and immune defenses, which help regulate microbial populations and protect the intestinal lining
Together, these systems help maintain a much smaller microbial population in the small intestine than in the colon.
Why Can Fermentation Cause Symptoms in SIBO?
SIBO can develop when intestinal motility, anatomy, digestive defenses, or other systems that normally regulate microbial numbers are disrupted.
When excess microorganisms are present in the small intestine, they may gain early access to carbohydrates and ferment them before those carbohydrates reach the colon.
The location of this fermentation matters. Gas produced in the small intestine can increase luminal distension, or the stretching of the inside of the intestine. In people with impaired gas transit or heightened intestinal sensitivity, that distension may contribute to symptoms such as:
Bloating
Visible abdominal distension
Abdominal discomfort, pain, or cramping
Belching or excessive gas
Diarrhea, constipation, or alternating bowel habits
Do Different Gases Produce Different Symptom Patterns?
Research suggests that different microbial gas patterns may be associated with different bowel habits, although these relationships are still being studied.
Hydrogen is central to carbohydrate fermentation, but it has not been associated as consistently with a single bowel-habit pattern. In a 2026 nationwide study of 6,000 people undergoing three-gas breath testing, methane was associated with constipation, while hydrogen sulfide was associated with diarrhea and higher overall symptom scores. A separate study found that breath methane and hydrogen sulfide levels correlated with relevant microorganisms in duodenal samples, strengthening the biological connection between gases measured in breath and microbial activity in the small intestine.
These findings describe patterns observed across groups rather than definitive diagnostic rules. Symptoms alone cannot determine which gas pattern or form of microbial overgrowth a person has.
How Does a SIBO Breath Test Work?
The biological basis of breath testing rests on an important principle: the hydrogen, methane, and hydrogen sulfide measured during gastrointestinal breath testing are produced by microorganisms rather than by human digestive cells.
During the test, a person provides a baseline breath sample, drinks a standardized test sugar, and then provides additional breath samples over the next two to three hours. As gut microorganisms ferment the sugar, they produce gases that can cross the intestinal wall, enter the bloodstream, travel to the lungs, and be released during exhalation. Clinicians interpret changes in gas levels over time to evaluate for fermentation occurring earlier than expected in the digestive tract or for excess methane production consistent with IMO.
How Are Breath-Test Gases Interpreted?
According to the North American Consensus on gastrointestinal breath testing, a rise in hydrogen of at least 20 parts per million above baseline by 90 minutes is considered a positive criterion for SIBO. An early rise in hydrogen is considered consistent with fermentation before the test sugar would normally reach the colon around 90 minutes.
A methane level of at least 10 parts per million at any point during the test is considered methane-positive and may support a diagnosis of IMO. Unlike hydrogen, methane is assessed throughout the test because methanogens can reside in both the small intestine and the colon, and methane production anywhere in the intestinal tract may be clinically significant.
The gas measurements should also be interpreted together. Methanogens and hydrogen-sulfide-producing microorganisms use hydrogen to produce methane and hydrogen sulfide, respectively. As a result, measured hydrogen levels may be lower when hydrogen is being used to produce methane or hydrogen sulfide.
Some newer breath-testing systems measure hydrogen sulfide in addition to hydrogen and methane. Research has linked breath hydrogen sulfide levels with hydrogen-sulfide-producing bacteria in duodenal samples. However, hydrogen sulfide testing is newer, and its diagnostic thresholds are not yet as widely standardized as those for hydrogen and methane. Breath-test findings should always be interpreted alongside a person’s symptoms, medical history, risk factors, and other clinical information.
The Takeaway
Microbial fermentation helps connect the symptoms, biology, and testing associated with SIBO. When excessive fermentation occurs in the small intestine, microbial gases may contribute to distension, discomfort, altered bowel habits, and, in more substantial cases, impaired nutrient absorption.
Because some of these gases can be measured in exhaled breath, breath testing offers a noninvasive way to identify patterns that may support SIBO or intestinal methanogen overgrowth diagnosis. However, results are indirect and should be interpreted alongside symptoms, medical history, risk factors, and other clinical findings.
Key References
Högenauer, C., Hammer, H. F., Mahnert, A., & Moissl-Eichinger, C. (2022). Methanogenic archaea in the human gastrointestinal tract. Nature Reviews Gastroenterology & Hepatology, 19(12), 805–813. https://doi.org/10.1038/s41575-022-00673-z
Lim, J., & Rezaie, A. (2023). Pros and cons of breath testing for small intestinal bacterial overgrowth and intestinal methanogen overgrowth. Gastroenterology & Hepatology, 19(3), 140–146.
Macfarlane, G. T., & Macfarlane, S. (2012). Bacteria, colonic fermentation, and gastrointestinal health. Journal of AOAC International, 95(1), 50–60. https://doi.org/10.5740/jaoacint.SGE_Macfarlane
Pimentel, M., Leite, G., Joo, L., Rezaie, A., Mathur, R., Brenner, D., Nguyen, L., Rashid, M., Hosseini, A., Brimberry, D., Mitcho, M., Richardson, D., & Wilfong, F. (2026). Real-world study of three-gas breath testing nationwide and the association with symptoms. Journal of Clinical Gastroenterology. Advance online publication.
Pimentel, M., Saad, R. J., Long, M. D., & Rao, S. S. C. (2020). ACG clinical guideline: Small intestinal bacterial overgrowth. The American Journal of Gastroenterology, 115(2), 165–178. https://doi.org/10.14309/ajg.0000000000000501
Quigley, E. M. M. (2019). The spectrum of small intestinal bacterial overgrowth. Current Gastroenterology Reports, 21(1), Article 3. https://doi.org/10.1007/s11894-019-0671-z
Rezaie, A., Buresi, M., Lembo, A., Lin, H., McCallum, R., Rao, S. S. C., Schmulson, M., Valdovinos, M., Zakko, S., & Pimentel, M. (2017). Hydrogen and methane-based breath testing in gastrointestinal disorders: The North American Consensus. The American Journal of Gastroenterology, 112(5), 775–784. https://doi.org/10.1038/ajg.2017.46
Rezaie, A., & Rao, S. S. C. (2023). Intestinal bacterial, fungal, and methanogen overgrowth. In S. S. C. Rao, H. P. Parkman, & R. W. McCallum (Eds.), Handbook of gastrointestinal motility and disorders of gut-brain interactions (2nd ed., pp. 205–221). Academic Press.
Villanueva-Millan, M. J., Leite, G., Morales, W., Joo, L., Weitsman, S., Mathur, R., Barlow, G. M., Rezaie, A., & Pimentel, M. (2025). Hydrogen sulfide and methane on breath test correlate with human small-intestinal hydrogen sulfide producers and methanogenic archaea. Digestive Diseases and Sciences. Advance online publication.
Zhang, D., Jian, Y.-P., Zhang, Y.-N., Li, Y., Gu, L.-T., Sun, H.-H., Liu, M.-D., Zhou, H.-L., Wang, Y.-S., & Xu, Z.-X. (2023). Short-chain fatty acids in diseases. Cell Communication and Signaling, 21, Article 212. https://doi.org/10.1186/s12964-023-01219-9